Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Pharmaceutical sector: Delicate transition

With lay-offs rife in the drug industry, life scientists and chemists are seeking fresh career paths.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Contract investigators

How to handle drug withdrawal

No drug for job haemorrhage

US scientists keep jobs

Drug buddies

Novartis to shut brain research facility

Pfizer slashes R&D

Related external links

Tufts Center for the Study of Drug Development

Drug Information Association

European Forum for Good Clinical Practice

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schubert, C. Pharmaceutical sector: Delicate transition. Nature 486, 281–283 (2012). https://doi.org/10.1038/nj7402-281a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nj7402-281a

Search

Quick links

Nature Briefing Careers

Sign up for the Nature Briefing: Careers newsletter — what matters in careers research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Careers